PrimeRFP SCOUT · Federal Contract Recompete Brief · MHS GENESIS

HT941025FE024Ancillary services — Acmesolv, LLC

Acmesolv, LLC holds $12.8M across 13 federal awards, concentrated at Department of Defense (DOD). Competition previously drew 15 offers. Recompete timing centers on the Aug 31, 2028 PoP end — agencies typically plan 12–18 months ahead.

Defense Health Agency Hcd West
Awarding office
Acmesolv, LLC
Recipient
Aug 31, 2028
PoP end
$6.3M
Obligated
$17.4M
Potential
621111
NAICS
Q502
PSC
MHS GENESIS
Vehicle
15 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Acmesolv, LLC — $90

Contract facts

Federal
Contract numberHT941025FE024
Also listed asHT001525D9013-HT941025FE024
AgencyDefense Health Agency Hcd West
Awarding officeDefense Health Agency Hcd West
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentAcmesolv, LLC
CAGE8NKV0
UEISBDDBRVCUXM9
NAICS621111
PSCQ502
VehicleMHS GENESIS
Parent IDIQ / IDVHT001525D9013
Place of performanceLAS VEGAS NV
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition After Exclusion Of Sources
PoP startSep 1, 2025
PoP end (current)Aug 31, 2028
Obligated$6.3M
Current value$6.4M
Potential value$17.4M

ANCILLARY SERVICES 33 FULL-TIME EQUIVALENTS AT MIKE OCALLAGHAN MILITARY MEDICAL CENTER NELLIS AIR FORCE BASE NEVADA is a federal award for Defense Health Agency Hcd West held by Acmesolv, LLC. Estimated value $17.4M ($6.3M obligated). Current period of performance ends Aug 31, 2028. Last award drew 15 bidders. Place of performance: LAS VEGAS NV.

ANCILLARY SERVICES 33 FULL-TIME EQUIVALENTS AT MIKE OCALLAGHAN MILITARY MEDICAL CENTER NELLIS AIR FORCE BASE NEVADA

Recompete timing

Public
Expiring in 741 days

Current PoP ends Aug 31, 2028 (741 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 3, 2027.

Incumbent footprint

Public record

Acmesolv, LLC$12.8M obligated across 13 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($12.8M) · all agencies
Department of Defense (DOD)$12.8M · 100%General Services Administration (GSA)$8K · 0%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract HT941025FE024?

HT941025FE024 (Ancillary services) is a Defense Health Agency Hcd West award with a potential value of $17.4M, currently held by Acmesolv, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded HT941025FE024?

Defense Health Agency Hcd West awarded HT941025FE024 to Acmesolv, LLC (potential $17.4M).

Who is the incumbent on HT941025FE024?

Acmesolv, LLC is the incumbent with $12.8M across 13 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2028.

When does Acmesolv, LLC’s HT941025FE024 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 31, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HT941025FE024